Form 13-F position report

UNITY BIOTECHNOLOGY INC

Reported by Russell Investments Group Ltd

UBX CUSIP 91381U101 Manager CIK 0001692234

Reported 0 shares, down 34,710 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q4 2021
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 10 Through Q4 2021

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 103000
2021-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

2 quarters
Quarterly reported position history for UNITY BIOTECHNOLOGY INC held by Russell Investments Group Ltd.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2021 Reduced 0 -34,710 (-100.0%) 0 $0 2022-01-21
Q3 2021 Reduced 34,710 -69,696 (-66.8%) < 0.01% $103,000 2021-11-08
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

94 managers reported UNITY BIOTECHNOLOGY INC for Q4 2021.

Managers reporting UNITY BIOTECHNOLOGY INC in Q4 2021.
Manager Activity Shares Change % of reported 13F Reported value Tenure
FMR LLC Reduced 3,106,530 -469,787 < 0.01% $4,535,000 15 qtrs
VANGUARD GROUP INC Added 1,778,809 +369,430 < 0.01% $2,597,000 15 qtrs
Invus Financial Advisors LLC Unchanged 1,094,998 0 0.49% $1,599,000 9 qtrs
RENAISSANCE TECHNOLOGIES LLC Added 1,077,700 +437,000 < 0.01% $1,573,000 3 qtrs
MARSHALL WACE LLP Added 891,977 +753,463 < 0.01% $1,303,000 3 qtrs
GSA CAPITAL PARTNERS LLP Added 696,115 +228,744 0.13% $1,016,000 3 qtrs
BAILLIE GIFFORD & CO Unchanged 589,111 0 < 0.01% $860,000 15 qtrs
BlackRock Inc Reduced 575,522 -325,108 < 0.01% $840,000 15 qtrs
MILLENNIUM MANAGEMENT LLC Added 551,908 +112,602 < 0.01% $806,000 3 qtrs
TWO SIGMA ADVISERS LP Added 522,700 +367,500 < 0.01% $763,000 4 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2021
Filed
January 21, 2022
Filing type
13F-HR
Position type
Common Stock

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.